ARMISARTE 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION

Actavis Group Ptc Ehf.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 53c36af9dead8d96
Drug Cima Aemps Name: ARMISARTE 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number: 1151063004
Holder Company Name: Actavis Group Ptc Ehf.
Marketing Company Name: Teva Pharma S.L.U.
Holder Company Detail Path: /organization/actavis-group-ptc-ehf
Authorization Date: 2021-01-19
Dosage Form: CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 25 mg/ml
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Actavis Group Ptc Ehf.
Company Detail Path: /organization/actavis-group-ptc-ehf

PEMETREXED

25 mg/ml

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jan 19, 2021

Approval ID

53c36af9dead8d96

Type

Standard